MULTIPLE SCLEROSIS

Patients with multiple sclerosis who were exposed to teriflunomide during pregnancy experienced similar risks of major birth defects and spontaneous abortions to the general population’s rates of 2% to 4% and 15% to 20%, respectively.
The senior preclinical and clinical imaging scientist at the National Institute of Neurological Disorders and Stroke spoke about the potential of the central vein sign to help improve the time to an accurate diagnosis in MS.

SAP Partner Banner

About NeurologyLive's Multiple Sclerosis Clinical Focus page:

The NeurologyLive Multiple Sclerosis Clinical Focus center offers the latest clinical news and expert insights related to this disabling disease of the central nervous system (CNS). Content found here includes video interviews with multiple sclerosis experts and key opinion leaders in neurology sharing insights on new and emerging therapies and management techniques, including insight and perspective novel treatment techniques. 

This page offers information regarding current strategies for multiple sclerosis treatment, as well as emerging therapeutic options for the disease being presented at major medical conferences and gaining traction in the scientific literature.